Free U.S. shipping $175+

CJC-1295 No DAC — Novaryn Research
Hover to zoom
Growth Hormone ResearchSynthetic research compound

CJC-1295 No DAC

$139.99
10 mg

CJC-1295 without DAC — also referred to as modified GRF (1–29) — is a GHRH analog carrying four amino-acid substitutions that improve resistance to enzymatic cleavage, but no albumin-binding group.

It is used in laboratory research as the short-duration counterpart to the DAC-modified version, allowing investigators to separate the contribution of sequence stabilization from the contribution of albumin binding.

Research areas
GHRH receptor signalingStructure–activity researchPeptide stability studiesPreclinical research
Form: Lyophilized (freeze-dried)
Compound class
Synthetic research compound
Research category
Growth Hormone Research
SKU
NVR-CJC-1295-NO-DAC-10MG
Appearance
Lyophilized powder
Storage
Store lyophilized at −20 °C. Protect from light and moisture.
Research use only
Strength
10 mg$139.99$14.00/mg
1
$139.99per 10 mg$14.00/mg

For research use only — not for human or animal consumption.

Supplied solely for legitimate laboratory and research purposes. Not for medical or veterinary use, diagnosis, treatment, or prevention of disease.

Research Grade
Batch Documentation
Research Use Only
U.S.-Based Fulfillment
What you should know

More detail on CJC-1295 No DAC.

Analytical values reflect per-lot documentation and appear once a batch is released.

Compound
Comparing the DAC and non-DAC forms of CJC-1295 is a clean way to study half-life extension in isolation, since both share the same substituted GHRH core. Without the albumin-binding group, this material clears far more quickly in preclinical models, producing a shorter and sharper receptor stimulus. Researchers use that difference to model pulsatile signaling, examine receptor recovery between stimuli, and validate assays where prolonged exposure would confound the readout. Supplied as a research reagent only.
Peptide class
Synthetic research compound
Mechanism (research context)
Extended mechanistic characterization for this compound is available in the published literature. Consult peer-reviewed references for detailed pathway analysis.
Why it is studied
CJC-1295 No DAC is studied within its research category (Growth Hormone Research) as a defined-sequence reference compound for laboratory investigation.
Current areas of research
GHRH receptor signalingStructure–activity researchPeptide stability studiesPreclinical research

Topics reflect published preclinical and in vitro research. Reference only — not a claim of clinical outcomes.

Scientific background

CJC-1295 No DAC is supplied for in vitro laboratory research. Batch-specific analytical documentation is provided when available for the released lot.

Related

Related research materials

View all →
CJC-1295 No DAC
10 mg · $139.99
Notify me when available